Omm Anantdrishti Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.00 M
- Revenue Growth %
- Profit Growth 56.52%
- Ebitda 91.13%
- Net Worth -0.55%
- Total Assets -1.30%
About Omm Anantdrishti Pharma
Omm Anantdrishti Pharma Private Limited (OAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 March 2014 and has a history of Ten years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anil Sharma and Neha Sharma serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2014PTC254650
-
Company No.
254650
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Mar 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Omm Anantdrishti Pharma Private Limited offer?
Omm Anantdrishti Pharma Private Limited offers a wide range of products and services, including Hair Shampoo, Herbal Shampoo, Sexual Wellness Products, Erectile Dysfunction Medicine, Allopathic Cough Syrup, Torex Cough Syrup, Ayurvedic & Herbal Health Supplement, Herbal Sexual Health Supplement, Pulses, Orid Dhall.
Who are the key members and board of directors at Omm Anantdrishti Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Sharma
|
Director | 19-Mar-2014 | Current |
|
Neha Sharma
|
Director | 19-Mar-2014 | Current |
Financial Performance of Omm Anantdrishti Pharma.
Omm Anantdrishti Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 56.52% increase in profit. The company's net worth dipped by a decrease of 0.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Omm Anantdrishti Pharma?
In 2017, Omm Anantdrishti Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹1.00 M
Charges Breakdown by Lending Institutions
- The Greater Bombay Co-Op Bank Ltd : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2015 | The Greater Bombay Co-Op Bank Ltd | ₹1.00 M | Satisfied |
How Many Employees Work at Omm Anantdrishti Pharma?
Unlock and access historical data on people associated with Omm Anantdrishti Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omm Anantdrishti Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omm Anantdrishti Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.